Shu Ning

12PUBLICATIONS
45CO-AUTHORS
Medical devicesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 22, 2026
Targeting ZIP12-mediated Zn2+ signaling as a treatment for pulmonary hypertension.

|May 05, 2026
Targeting NDUFS4 Disrupts Oxidative Phosphorylation and Induces Ferroptosis in Olaparib-Resistant Prostate Cancer.

|Dec 05, 2025
IGFBP3-SphK1/S1P Signaling Axis Drives Enzalutamide Resistance in Advanced Prostate Cancer.

Amy R Leslie, Shu Ning, Masuda Sharifi

|Jun 26, 2025
Steroid Sulfatase Regulates Metabolic Reprogramming in Advanced Prostate Cancer.

Masuda Sharifi, Cameron M Armstrong, Shu Ning

|Oct 23, 2024
PINK1-Mediated Mitochondrial Activity Confers Olaparib Resistance in Prostate Cancer Cells.

Zachary A Schaaf, Shu Ning, Amy R Leslie

|Aug 01, 2024
LX1 Dual Targets AR Variants and AKR1C3 in Advanced Prostate Cancer Therapy.

Shu Ning, Cameron M Armstrong, Enming Xing

Pageof 2

Frequent Collaborators

7 joint publications

Alan P Lombard

7 joint publications

Chengfei Liu

7 joint publications

Amy R Leslie

7 joint publications

Masuda Sharifi